Your browser doesn't support javascript.
loading
LEFTY1 Is a Dual-SMAD Inhibitor that Promotes Mammary Progenitor Growth and Tumorigenesis.
Zabala, Maider; Lobo, Neethan A; Antony, Jane; Heitink, Luuk S; Gulati, Gunsagar S; Lam, Jessica; Parashurama, Natesh; Sanchez, Kassandra; Adorno, Maddalena; Sikandar, Shaheen S; Kuo, Angera H; Qian, Dalong; Kalisky, Tomer; Sim, Sopheak; Li, Linus; Dirbas, Frederick M; Somlo, George; Newman, Aaron; Quake, Stephen R; Clarke, Michael F.
Afiliação
  • Zabala M; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Lobo NA; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Antony J; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Heitink LS; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Gulati GS; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Lam J; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Parashurama N; Department of Chemical and Biological Engineering, State University of New York at Buffalo, Buffalo, NY, USA.
  • Sanchez K; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Adorno M; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Sikandar SS; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Kuo AH; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Qian D; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Kalisky T; Department of Bioengineering, Stanford University, Stanford, CA, USA.
  • Sim S; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Li L; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Dirbas FM; Department of Surgery, Stanford University School of Medicine, Stanford Cancer Institute, Stanford, CA, USA.
  • Somlo G; City of Hope Comprehensive Cancer Center, Duarte, CA, USA.
  • Newman A; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA.
  • Quake SR; Department of Bioengineering, Stanford University, Stanford, CA, USA; Chan Zuckerburg Biohub, San Francisco, CA, USA.
  • Clarke MF; Institute for Stem Cell Biology and Regenerative Medicine, School of Medicine, Stanford University, Stanford, CA, USA; Department of Medicine, Stanford University, Stanford, CA, USA; Chan Zuckerburg Biohub, San Francisco, CA, USA. Electronic address: mfclarke@stanford.edu.
Cell Stem Cell ; 27(2): 284-299.e8, 2020 08 06.
Article em En | MEDLINE | ID: mdl-32693087
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Fator de Crescimento Transformador beta Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transdução de Sinais / Fator de Crescimento Transformador beta Idioma: En Ano de publicação: 2020 Tipo de documento: Article País de afiliação: Estados Unidos